Clinical Trial

Parkinson's Disease Inflammatory Biomarker Profiling

Study Description

Parkinson's Disease Inflammatory Biomarker Profiling

This study compares a comprehensive panel of immunological biomarkers between Parkinson's disease patients and healthy, environmentally matched participants. This unique study design provides the ability to control for differences in environment between study subjects. The goal of this study is to 1) identify a specific set of immunological markers that correlate with a clinical diagnosis of Parkinson's disease and 2) stratify patients by disease severity using these same biomarkers.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Diagnostic Test - LBT-3627

Immunomodulatory agent

Diagnostic Test - Immunological profiling

Comprehensive profiling of inflammatory and anti-inflammatory markers (incl. cellular, molecular) including cellular functional assays

Additional Information

Official Study Title

Inflammatory Parkinson's Disease (PD) Clinical Biomarker Profiling in T Cells

Clinical Trial ID

NCT03633513

ParticipAid ID

b4xRVb